IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES TAKEDA SUBSIDIARY LISTING
Prin ci pal Prod ucts:
AMIAS (an gio ten sin-II an tag o nist plain)
ACTOS (antidiabetic oral)
COMPETACT (antidiabetic oral)
Ther a peu tic Range:
renin-an gio ten sin sys tem agents 62%
drugs used in di a be tes 38%
Lead ing Dose Forms:
tab lets 97%
coated tab lets 3%
TAKEDA CAM BRIDGE
Full Name: Takeda Cam bridge Lim ited
Street Ad dress: 418 Cam bridge Sci ence Park,
Cam bridge, Cam bridge shire CB4 0PA
Tel: +44 1223 477910
Fax: +44 1223 477911
Sub sid iary of: Takeda, Neth er lands (100%)
TAKEDA GLOBAL R&D
Full Name: Takeda Global Re search & De vel op -
ment Cen tre (Eu rope) Ltd.
Street Ad dress: Arundel Great Court, 2 Arundel
Street, Lon don, WC2R 3DA
Tel: +44 20 7759 5000
Fax: +44 20 7759 5270
De scrip tion: Es tab lished 1994. Pre vi ously
known as Takeda Euro R&D.
Sub sid iary of: Takeda, Neth er lands (100%)
TAKEDA PHARMA
Full Name: Takeda Pharmaceuticals Eu rope Lim -
ited
Street Ad dress: 55 New Ox ford Street, Lon don,
WC1A 1BS
Tel: +44 20 7632 9300
Fax: +44 20 7632 9309
De scrip tion: Hold ing com pany. Es tab lished
1998. Pre vi ously known as Takeda Eu rope Hold -
ings.
Con tacts (Pharm): Chair man: Giacomo De
Nepi; Com mer cial Op er a tions: Da vid Rob erts
Sub sid iary of: Takeda, Neth er lands (100%)
� USA
MIL LEN NIUM
Full Name: Mil len nium Pharmaceuticals Inc
Street Ad dress: 40 Landsdowne Street, Cam -
bridge, Mas sa chu setts 02139
Tel: +1 617 679 7000
Fax: +1 617 374 7788
Email: info@mlnm.com
Home Page: www.mlnm.com
De scrip tion: Re searcher, de vel oper,
sales/detailer. Re searches, de vel ops for other
com pa nies. Prod uct ranges in clude: phar ma ceu ti -
cal prod ucts (branded, pre scrip tion), hos pi tal
pharmaceuticals, bio tech nol ogy prod ucts, di ag -
nos tic prod ucts. Established 1993.
Con tacts (Pharm): Chair man: Mark J. Levin;
Com mer cial Op er a tions: Theresa McNeely; Man u -
fac ture: James Nash; Re search & De vel op ment:
Charles Homcy, Rob ert Tepper, Dr Jo seph Bolen;
Gen eral Con tact: Clare Midgely
Par ent of: Mil len nium, UK.
Sub sid iary of: Takeda, Ja pan (100%) (ac quired
2008)
Phar ma ceu ti cal Sales: US$ 330-340 mil lion
Prod ucts (% of Sales by Lead ing 5):
95-100%
Ther a peu tic Classes (% of Sales by Lead ing
5): n.a.
Dose Forms (% of Sales by Lead ing 5): n.a.
Prin ci pal Prod ucts:
VELCADE (antineoplastic other)
Ther a peu tic Range:
antineoplastics 100%
Lead ing Dose Forms:
vi als 100%
TAKEDA
Full Name: Takeda Pharmaceuticals North
Amer ica, Inc.
Street Ad dress: One Takeda Park way,
Deerfield, Il li nois 60015
Tel: +1 224 554 6500
Email: busdev@tpna.com
Home Page: www.tpna.com
De scrip tion: Re searcher, de vel oper, for mu la tor,
pro moter, sales/detailer. Pro motes, sells/de tails
for other com pa nies. Prod uct ranges in clude:
phar ma ceu ti cal prod ucts (branded, pre scrip tion).
Es tab lished 1998. 3,183 phar ma ceu ti cal
employees in 2007.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): over 2,001 (2007)
Con tacts (Pharm): Chair man: Mark Booth;
Com mer cial Op er a tions: Dan iel Or lando (Sales),
An drew Hull (Mar ket ing); Re search & De vel op -
ment: Dr Mehmood Khan; Gen eral Con tact:
Matthew Kuhn
Par ent of: Takeda Global R&D, USA (100%).
Sub sid iary of: Takeda Amer ica Hold ings, USA
(100%)
© 2009 IMS Health In cor po rated or its af fil i ates Page 130